Back

Volume 25 , Issue 2
March/April 2005
Pages 129–137

Clinical Case Reports of Injectable Tissue-Engineered Bone for Alveolar Augmentation with Simultaneous Implant Placement

Minoru Ueda, DDS, PhD/Yoichi Yamada, DDS, PhD/Ryotaro Ozawa, DDS/Yasuhiro Okazaki, DDS, PhD

PMID: 15839589
DOI: 10.11607/prd.00.0630

This clinical study was undertaken to evaluate the use of tissue-engineered bone, mesenchymal stem cells, platelet-rich plasma, and beta-tricalcium phosphate as grafting materials for maxillary sinus floor augmentation or onlay plasty with simultaneous implant placement in six patients with 3- to 5-mm alveolar crestal bone height. All 20 implants were clinically stable at second-stage surgery and 12 months postloading. A mean increase in mineralized tissue height of 7.3 ± 4.6 mm was evident when comparing the pre- and postsurgical radiographs. Injectable tissue-engineered bone provided stable and predictable results in terms of implant success. (Int J Periodontics Restorative Dent 2005;25:129–137.)

Full Text PDF File | Order Article

 

 

Adobe Acrobat Reader is required to view PDF files. This is a free program available from the Adobe web site.
Follow the download directions on the Adobe web site to get your copy of Adobe Acrobat Reader.